Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Delia Yu"'
Autor:
Phirangkul Kerdpanich, Pornthep Chanthavanich, Mari Rose De Los Reyes, Jodor Lim, Delia Yu, Ma Cecilia Ama, Zenaida Mojares, Daniela Casula, Ashwani Kumar Arora, Michele Pellegrini
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 12, Iss 6, p e0006340 (2018)
This phase III clinical trial compared the immunogenicity and safety of a purified chick-embryo cell rabies vaccine (PCECV) administered according to a shortened post-exposure prophylaxis (PEP) 4-site/1-week intradermal regimen, compared with the cur
Externí odkaz:
https://doaj.org/article/5a4dc1cee2d24b84a83bdd13b14f40ab
Autor:
Felix Espinoza, Edson D. Moreira, Inge Lefevre, Maria Theresa Alera, Asvini D. Fernando, Mengya Liu, Delia Yu, Pope Kosalaraksa, Luis Rivera, Vianney Tricou, Martina Rauscher, Hector Velásquez, Pujitha Wickramasinghe, Dulanie Gunasekera, Derek Wallace, Lulu Bravo, Luis Martinez Vargas, Xavier Sáez-Llorens, Rivaldo Venâncio da Cunha, Veerachai Watanaveeradej, Astrid Borkowski, Charissa Borja-Tabora, Kleber Giovanni Luz, Edith Johana Rodriguez-Arenales, Chukiat Sirivichayakul, Reynaldo Dietze, Shibadas Biswal, Humberto Reynales, Eduardo López-Medina, LakKumar Fernando
Publikováno v:
The Journal of Infectious Diseases. 225:1521-1532
Background Takeda’s dengue vaccine is under evaluation in an ongoing phase 3 efficacy study; we present a 2-year update. Methods Children (20 099, 4–16 years old) were randomized to receive 2 doses of TAK-003 or placebo 3 months apart and are und
Autor:
Shibadas Biswal, Charissa Borja-Tabora, Luis Martinez Vargas, Hector Velásquez, Maria Theresa Alera, Victor Sierra, Edith Johana Rodriguez-Arenales, Delia Yu, V Pujitha Wickramasinghe, Edson Duarte Moreira, Asvini D Fernando, Dulanie Gunasekera, Pope Kosalaraksa, Felix Espinoza, Eduardo López-Medina, Lulu Bravo, Suely Tuboi, Yanee Hutagalung, Pedro Garbes, Ian Escudero, Martina Rauscher, Svetlana Bizjajeva, Inge LeFevre, Astrid Borkowski, Xavier Saez-Llorens, Derek Wallace, Alys Concepción, Ana Cecilia Villarreal, Asvini Fernando, Chukiat Sirivichayakul, Edith Johanna Rodriguez-Arenales, Humberto Reynales, Kleber Luz, Jose Jimeno, LakKumar Fernando, Luis Rivera, Onanong Manacharoen, Pio Lopez, V. Pujitha Wickramasinghe, Reynaldo Dietze, Rivaldo Venâncio da Cunha, Veerachai Watanaveeradej, Manja Brose, Kelley Moss, Seetha Meyer, Vianney Tricou
Publikováno v:
The Lancet. 395:1423-1433
A substantial unmet need remains for safe and effective vaccines against dengue virus disease, particularly for individuals who are dengue-naive and those younger than 9 years. We aimed to assess the efficacy, safety, and immunogenicity of a live att
Autor:
Shibadas Biswal, Reynaldo Dietze, Martina Rauscher, Mengya Liu, Delia Yu, Inge Lefevre, Humberto Reynales, Luis Rivera, Vianney Tricou, Eduardo López-Medina, Pope Kosalaraksa, Lulu Bravo, Charissa Borja-Tabora, Chukiat Sirivichayakul, Edson D. Moreira, Dulanie Gunasekera, Astrid Borkowski, Luis Vargas, Maria Theresa Alera, Derek Wallace, Veerachai Watanaveeradej, Kleber Giovanni Luz, Lakkumar Fernando, Xavier Sáez-Llorens, Rivaldo Venâncio da Cunha, Elaine Hoffman, Pujitha Wickramasinghe, Felix Espinoza, Olaf Zent, Asvini D. Fernando
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 75(1)
Background Takeda’s live attenuated tetravalent dengue vaccine candidate (TAK-003) is under evaluation in a long-term clinical trial across 8 dengue-endemic countries. Previously, we have reported its efficacy and safety in both seronegative and se
Autor:
Rodrigo DeAntonio, Derek Wallace, Xavier Sáez-Llorens, Maria Vargas, Debbie Mendoza, Onix De Suman, Astrid Borkowski, Inge Lefevre, Martina Rauscher, Manja Brose, Ana Cecilia Villarreal, Suely Tuboi, Nathali Montenegro, Sonia Mazara, Delia Yu, Luis Rivera, Epiphany Dato, Vianney Tricou, José Jimeno
Publikováno v:
Lancet (London, England). 395(10234)
Summary Background An unmet clinical need remains for an effective tetravalent dengue vaccine suitable for all age groups, regardless of serostatus. We assessed the immunogenicity and safety of three different dose schedules of a tetravalent dengue v
Autor:
Derek Wallace, Manja Brose, Ana Cecilia Villarreal, Xavier Sáez-Llorens, Epiphany Dato, Suely Tuboi, Vianney Tricou, Sonia Mazara, José Jimeno, Maria Vargas, Delia Yu, Luis Rivera, Astrid Borkowski, Martina Rauscher
Publikováno v:
The Lancet Infectious Diseases. 18:162-170
Summary Background Development of vaccines that are effective against all four dengue virus serotypes (DENV-1–4) in all age groups is important. Here, we present 18-month interim data from an ongoing study undertaken to assess the immunogenicity an
Autor:
Pedro Garbes, Delia Yu, Astrid Borkowski, Derek Wallace, Vianney Tricou, Xavier Sáez-Llorens, Luis Rivera, Suely Tuboi
Publikováno v:
The Lancet Infectious Diseases. 17:615-625
Summary Background Dengue is the most common mosquito-borne viral disease in human beings, and vector control has not halted its spread worldwide. A dengue vaccine for individuals aged 9 years and older has been licensed, but there remains urgent med
Autor:
Beatriz Minguez, Mariela de Los Santos, Camila Garcia-Volpe, Cristina Molera, Abraham J. Paredes-Fuentes, Clara Oliva, Angela Arias, Helena Rodriguez-Gonzalez, Delia Yubero, Mireia Tondo, Carlos Santos-Ocaña, Silvia Meavilla, Rafael Artuch
Publikováno v:
Antioxidants, Vol 13, Iss 8, p 966 (2024)
Coenzyme Q10 (CoQ) is a ubiquitous lipid with different biological functions. In blood, there is a close relationship between CoQ status and cholesterol, which strongly supports the study of both molecules simultaneously. The objective of this study
Externí odkaz:
https://doaj.org/article/8b868ec7b67e4dc5a1dc96c127b67f01
Autor:
Mari Rose De Los Reyes, Zenaida Mojares, Ma. Cecilia G. Ama, Delia Yu, Michele Pellegrini, Jodor Lim, Ashwani Kumar Arora, Daniela Casula, Phirangkul Kerdpanich, Pornthep Chanthavanich
Publikováno v:
PLoS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases, Vol 12, Iss 6, p e0006340 (2018)
PLoS Neglected Tropical Diseases, Vol 12, Iss 6, p e0006340 (2018)
Background This phase III clinical trial compared the immunogenicity and safety of a purified chick-embryo cell rabies vaccine (PCECV) administered according to a shortened post-exposure prophylaxis (PEP) 4-site/1-week intradermal regimen, compared w
Autor:
Sonia Emperador, Nuria Garrido-Pérez, Javier Amezcua-Gil, Paula Gaudó, Julio Alberto Andrés-Sanz, Delia Yubero, Ana Fernández-Marmiesse, Maria M. O’Callaghan, Juan D. Ortigoza-Escobar, Marti Iriondo, Eduardo Ruiz-Pesini, Angels García-Cazorla, Mercedes Gil-Campos, Rafael Artuch, Julio Montoya, María Pilar Bayona-Bafaluy
Publikováno v:
Frontiers in Genetics, Vol 10 (2020)
Encephalomyopathic mitochondrial DNA (mtDNA) depletion syndrome 13 (MTDPS13) is a rare genetic disorder caused by defects in F-box leucine-rich repeat protein 4 (FBXL4). Although FBXL4 is essential for the bioenergetic homeostasis of the cell, the pr
Externí odkaz:
https://doaj.org/article/3d23431fa04641679dcfda334d4bd917